Spineology notes positive OptiMesh data in spinal fusion procedures for degenerative disc disease

Neurosurgeon John Chi, MD, presented positive 24-month outcomes data of the OptiMesh implant in the Spineology Clinical Outcomes Trial at the Society for Minimally Invasive Spine Surgery Annual Meeting in Las Vegas from Oct. 31 to Nov. 2.

Advertisement

Five things to know:

1. OptiMesh is Spineology’s porous graft containment mesh that deploys within the disc as its is filled, allowing the bone graft to conform to the vertebral body endplates.

2. The SCOUT trial studied 102 patients suffering from painful lumbar degenerative disc disease for at least six months.

3. Significant reductions in lumbar pain and functional limitations were noted at six, 12 and 24 months.

4. Roughly 90 percent of patients reported “excellent” or “good” patient satisfaction levels at six, 12 and 24 months with current data through 24 months yielding a fusion rate of 98 percent.

5. Seventeen of the 102 subjects are still to complete the 24-month follow-up date.

More articles on devices:
Dr. Sergiy Nesterenko opens spine clinic in Texas
California hospital adds 7 neurosurgeons to curb patient leakage
Drs. Nic Gay, Kerisimasi Reynolds team to form Silicon Valley Orthopaedics

Advertisement

Next Up in Spinal Tech

  • Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

Advertisement

Comments are closed.